Mar 9, 2023, 09:40 AM by

Micropep Technologies appoints Alexandre Frateschi as chief business officer, signaling drive to agTech product commercialization.

Mar 9, 2023, 01:00 AM by User Not Found

Bio-IT World | Kevin Davies and Craig Venter sat down together to celebrate thirty years of the Molecular and Precision Med Tri-Con this week in San Diego on Monday night. Davies—the founding editor of Bio-IT World—gave a guided tour of human genomic research and sequencing since 1991 with Venter offering first person color commentary along the way.

Mar 8, 2023, 10:07 AM by

PRODUCT BRIEF – March 7, 2023 Thermo Fisher Scientific Introduces New Low-Flow HPLC Columns for Proteomic Research Thermo Scientific µPAC Neo HPLC Columns Deliver Improved Separation Performance and Stability for Biologically Complex Samples News: Thermo Fisher Scientific is providing proteomics and biopharmaceutical research laboratories with a new line of low-flow HPLC columns that improve separation performance and stability of biologically complex samples. Overview: Using a unique micro-pillar separation structure, the Thermo Scientific µPAC Neo HPLC Columns enable researchers to investigate proteomics samples in greater detail, from accurate identification of peptides to determination of protein quantities, discovery of disease biomarkers and post-translational modifications. The newest addition to the portfolio is the µPAC Neo low-load trapping column which is ideally suited for the smallest samples sizes in single-cell proteomics separations and features built-in nanoViper connections to the Vanquish Neo UHPLC systems for ease of use and reduced risk of errors. Users of all µPAC Neo columns benefit from excellent column reproducibility, allowing for more reliable data interpretation and confidence in their results. The full µPAC Neo column portfolio offers: • 50 cm µPAC Neo column for routine proteomics • 110 cm µPAC Neo column for comprehensive proteomics • 50 cm µPAC Neo low-load column for single-cell proteomics • µPAC Neo low-load trapping column to support single-cell proteomics separations µPAC Neo columns are manufactured by micromachined etching of silicon wafers, resulting in highly reproducible separation paths. For proteomics researchers, this provides higher column-to-column consistency and longer column lifetimes compared to packed-bed columns, allowing for more robust development and validation of methods and easier study of larger sample batches. Key Applications: Proteomics and biopharmaceutical research Features/Benefits: • Unique column technology that delivers optimal sample coverage and improved protein identification • Extra-high resolution separations of highest complexity samples • Excellent column reproducibility for more reliable data interpretation • Long column lifetimes to reduce the number of column exchanges and increase system uptime Website: To learn more about the new µPAC Neo HPLC Columns, please visit www.thermofisher.com/lowflowHPLCcolumns. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Mar 8, 2023, 10:06 AM by

DCT platform company places in top 6% of private companies; recognized for end-to-end clinical trial execution built on cutting-edge software

Mar 8, 2023, 01:00 AM by User Not Found

Bio-IT World | A research collaboration led by led by Duke-NUS Medical School and National Heart Centre Singapore has set the stage for telomere measurement to one day be added to the list of clinical-grade methods for assessing biological aging. The focus is on rapid and precise measurement of individual telomeres using a technique that employs “telobaits” that latch onto the ends of telomeres in large pools of DNA fragments.

Mar 7, 2023, 09:27 AM by

Mar 7, 2023, 09:26 AM by

A Pharmacogenomic Breakthrough Translating Personalized Gene Expression to Therapies

Mar 7, 2023, 09:14 AM by User Not Found

Bio-IT World | Sarah Hersey, VP of Precision Medicine at Bristol Myers Squibb, gave a balanced view of the challenges and opportunities facing precision medicine in her keynote address at the Molecular & Precision Medicine Tri-Conference in San Diego this week. After her presentation she was joined by others in the space to talk about the future for diagnostics and precision medicine.

Mar 6, 2023, 14:14 PM by

PubHive customers can now enable users to automatically sign-on to the PubHive Navigator cloud software platform using secure single sign-on technology powered by Microsoft Azure Active Directory

Mar 6, 2023, 14:10 PM by

Mar 6, 2023, 14:07 PM by

Alfa Chemistry, a chemical company focused on supplying high-quality chemicals and materials for both academia and the industry, today announced that members of its Senior Management Team are scheduled to participate in the upcoming ACS Spring 2023 Conference in March at Indiana Convention Center, located in 100 S Capitol Ave, Indianapolis, IN 46225.

Mar 3, 2023, 10:13 AM by

The New York-based chemical vendor Alfa Chemistry recently announced its attendance at the upcoming Pittcon Conference & Exposition 2023. This five-day event will take place at Pennsylvania Convention Center from 18th – 22nd March 2023.

Mar 3, 2023, 10:12 AM by

Mar 3, 2023, 10:12 AM by

Mar 3, 2023, 10:11 AM by

Mar 3, 2023, 10:11 AM by

Equiva Health recently announced a partnership with the Cancer Support Community—the largest professionally led non-profit cancer support network—to launch a pilot program in Minnesota to bring a new, digital model of cancer care to communities that lack access. CSC will use Equiva’s health relationship management platform to bring CSC’s services and resources to patients via broadband-enabled tablets. Those who qualify will also be able to apply for the FCC’s Affordable Connectivity Program via Equiva and ISP provider Infiniti Mobile, providing low to no-cost broadband connection to support access to CSC's resources Overall this partnership is an effort to bring digital cancer care and telemedicine services to underserved communities to improve health equity among these populations.

Mar 2, 2023, 14:38 PM by

Form Bio, the breakthrough computational life sciences platform, today announced the appointment of Linda Murray as Chief Financial Officer.

Mar 2, 2023, 14:38 PM by

Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain

Mar 2, 2023, 10:08 AM by

BRIM Biotechnology Inc. ("BRIM," TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, announced today that the first patient has been enrolled in its Phase 3 clinical trial of BRM421 for the treatment of Dry Eye Disease (DED).

Mar 2, 2023, 10:08 AM by